International Conference on Pharmacy, General Drug Categories and Drug Action
ICPGDCDA
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest research and developments in pharmacology, emphasizing the mechanisms of drug action and their therapeutic implications. Participants will explore novel pharmacological agents and their roles in treating various diseases.
SDG 3
SDG 4
This session will highlight cutting-edge techniques in medicinal chemistry, including drug design and synthesis. Discussions will center on the relationship between chemical structure and biological activity.
SDG 9
This track addresses the integration of clinical pharmacology into direct patient care practices. It will explore personalized medicine approaches and their impact on treatment outcomes.
SDG 3
SDG 9
Participants will delve into the principles of pharmacodynamics and pharmacokinetics, examining how drugs interact with biological systems. The session will cover factors influencing drug absorption, distribution, metabolism, and excretion.
SDG 3
This session focuses on the safety profiles of pharmaceutical agents, including the study of toxicological effects and risk assessment. Researchers will present findings on adverse drug reactions and their implications for public health.
SDG 3
SDG 16
This track will explore the effects of drugs on the nervous system, including mechanisms of action and therapeutic applications in mental health. Participants will discuss the role of pharmacotherapy in managing neurological and psychiatric disorders.
SDG 3
SDG 4
This session emphasizes the intersection of chemical biology and drug discovery, focusing on the identification and characterization of bioactive compounds. Researchers will present innovative methodologies for drug development.
SDG 3
SDG 9
This track will cover advancements in laboratory medicine, including molecular diagnostics and their role in disease management. Discussions will focus on the integration of laboratory findings into clinical practice.
SDG 3
SDG 9
Participants will examine various drug classes and their therapeutic applications across different medical conditions. This session will highlight the specificity and potency of drugs within these classes.
SDG 3
SDG 9
This track will explore the molecular and cellular mechanisms underlying signal transduction pathways. Researchers will discuss how these pathways influence drug action and therapeutic efficacy.
SDG 3
SDG 4
This session will focus on the evolving role of pharmacy practice in healthcare delivery. Topics will include the integration of pharmacists in patient care teams and the impact of pharmacy-led initiatives on health outcomes.
SDG 3
SDG 4